Abstract |
The perioperative management of patients with pulmonary hypertension requires an in-depth knowledge of the underlying disease, its related pathophysiology, effects of anaesthesia and surgery, as well as the appropriate pharmacotherapy. With respect to preoperative assessment, it is essential to review all available diagnostic findings, evaluate the patient's physical state, and to plan the anaesthetic procedure. Intraoperatively, the prevention of increases in pulmonary resistance and right ventricular decompensation appears essential. For this purpose, stress, hypothermia, decreased systemic perfusion, hypercapnia, hypoxemia, acidosis, and invasive mechanical ventilation should be avoided. If the pulmonary artery pressure exacerbates, application of inhaled nitric oxide or prostacyclins ( iloprost), phosphodiesterase-III-inhibitors ( milrinone) and phosphodiesterase-V-inhibitors ( sildenafil), reflect first-line treatment options. In order to support the right ventricle, inotropes (adrenalin, dobutamine, levosimendan) or inodilators ( milrinone) increase its contractility. Dependent on severity of disease and the magnitude of surgical intervention, patients with pulmonary hypertension require a specific continuous monitoring as well as trained staff in the postoperative period.
|
Authors | Alexander Hötzel, Torsten Loop |
Journal | Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
(Anasthesiol Intensivmed Notfallmed Schmerzther)
Vol. 54
Issue 5
Pg. 334-346
(May 2019)
ISSN: 1439-1074 [Electronic] Germany |
Vernacular Title | Pulmonale Hypertonie: anästhesiologisches Management. |
PMID | 31083758
(Publication Type: Journal Article, Review)
|
Copyright | Georg Thieme Verlag KG Stuttgart · New York. |
Chemical References |
- Anesthetics
- Vasodilator Agents
- Nitric Oxide
- Sildenafil Citrate
- Milrinone
|
Topics |
- Anesthesia, General
- Anesthetics
(therapeutic use)
- Humans
- Hypertension, Pulmonary
- Milrinone
(therapeutic use)
- Nitric Oxide
(therapeutic use)
- Sildenafil Citrate
(therapeutic use)
- Vasodilator Agents
|